DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

GlaxoSmithKline (NYSE: GSK)

43.61 -0.06 (-0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $43.61 -0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.43
Previous Close $43.67
Daily Range $43.30 - $43.68
52-Week Range $41.91 - $56.73
Market Cap $104.8B
P/E Ratio 15.01
Dividend (Yield) $2.59 (6.1%)
Ex-Dividend Date
Dividend Pay Date
08/06/14
10/02/14
Volume 4,074,323
Average Daily Volume 6,220,419
Current FY EPS $3.14

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Should Ebola Fear... Tobacco?

Ebola vaccine production could get a lift thanks to tobacco plants.

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

Healthcare Stocks in Focus on Ebola Fears - Analyst Blog

Diamond Hill Capital Comments on GlaxoSmithKline PLC

Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

Update: Why Theravance Jumped

Novartis Presents Encouraging Data on Leukemia Candidate - Analyst Blog

GlaxoSmithKline (GSK) Is Today's Pre-Market Laggard Stock

Best 3 Yielding Buy-Rated Stocks: GSK, PSEC, PCL

FDA Sends Mixed Message On Safety of Pfizer inc.'s Chantix

The smoking cessation product might not cause neuropsychiatric events, but the FDA wants more data.

See More GSK News...

GSK's Top Competitors

GSK $43.61 (-0.14%)
Current stock: GSK
JNJ $99.20 (0.51%)
Current stock: JNJ
NVS $87.90 (1.47%)
Current stock: NVS
PFE $27.93 (0.36%)
Current stock: PFE